SCHEMBL5169937

SCHEMBL5169937

CCCP(CCC)CCCP(CCC)CCC

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.33
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15660103 1.00 TSHR (0.33) TSHRLMNATHRB
SCHEMBL15659600 1.00 TSHR (0.33) TSHRLMNATHRB
SCHEMBL15657106 0.92 TSHR (0.33) TSHRLMNATHRB
SCHEMBL9074602 0.92 TSHR (0.33) TSHRLMNATHRB
SCHEMBL15657060 0.92 TSHR (0.33) TSHRLMNATHRB
SCHEMBL9494791 0.90
SCHEMBL1725820 0.89 TSHR (0.40) TSHRLMNATHRB
SCHEMBL15656261 0.89 TSHR (0.38) TSHRLMNATHRB
SCHEMBL15659007 0.89 TSHR (0.38) TSHRLMNATHRB
SCHEMBL15659911 0.89 TSHR (0.38) TSHRLMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167144-A1 PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) 2023-06-01 US claimed
US-20230167144-A1 PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) 2023-06-01 US disclosed
EP-2735581-B1 COMPOSITION AND POLYMER ASAHI CHEMICAL IND (JP) 2021-07-14 EP disclosed
US-9738757-B2 Composition and polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2017-08-22 US disclosed
US-20160222168-A1 Composition and Polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-08-04 US disclosed
US-9334371-B2 Composition and polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-05-10 US disclosed
US-9290525-B2 Method for producing cyclic silane compound or salt thereof, salt having cyclic silane dianion, and cyclic silane dianion salt-containing composition NIPPON SHOKUBAI CO., LTD. (JP) 2016-03-22 US disclosed
EP-2735581-A1 COMPOSITION AND POLYMER Asahi Kasei Chemicals Corporation (JP) 2014-05-28 EP disclosed
US-20140121293-A1 Composition and Polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-05-01 US disclosed
US-20140012030-A1 METHOD FOR PRODUCING CYCLIC SILANE COMPOUND OR SALT THEREOF, SALT HAVING CYCLIC SILANE DIANION, AND CYCLIC SILANE DIANION SALT-CONTAINING COMPOSITION NIPPON SHOKUBAI CO., LTD. (JP) 2014-01-09 US disclosed
EP-0495547-B1 Carbonylation of olefins SHELL INT RESEARCH (NL) 1996-04-24 EP disclosed
US-5359028-A Polyketone polymers SHELL OIL COMPANY (US) 1994-10-25 US disclosed
EP-0577204-A2 Preparation of alkanedioic derivatives SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1994-01-05 EP disclosed
US-5214220-A Hydrogenation of aldehydes, Group VIII metal compound, bidentate phosphine SHELL OIL COMPANY (US) 1993-05-25 US disclosed
EP-0283586-B1 HOMOLOGATION PROCESS UNION CARBIDE CORPORATION (US) 1993-03-17 EP disclosed
EP-0529698-A2 Process for the preparation of alcohols SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1993-03-03 EP disclosed
EP-0495547-A2 Carbonylation of olefins SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1992-07-22 EP disclosed
US-4902833-A Bisphosphine dioxides UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) 1990-02-20 US disclosed
EP-0283586-A2 Homologation process UNION CARBIDE CORPORATION (US) 1988-09-28 EP disclosed
US-4727200-A RHODIUM-BASED CATALYST; MILD CONDITIONS UNION CARBIDE CORPORATION (US) 1988-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140012030-A1 METHOD FOR PRODUCING CYCLIC SILANE COMPOUND OR SALT THEREOF, SALT HAVING CYCLIC SILANE DIANION, AND CYCLIC SILANE DIANION SALT-CONTAINING COMPOSITION PKD1, CHAMP1, SAV1 TSHR 4368/4885LMNA 3572/4885THRB 4277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.